Canonic Received Approval for Propagation of Medical Cannabis from the Israel Medical Cannabis Agency
This approval will allow Canonic to proceed with the execution of its commercialization plan REHOVOT, Israel, Nov. 11, 2020 /PRNewswire/ — Canonic, a wholly owned subsidiary of Evogene Ltd. (NASDAQ: EVGN), (TASE: EVGN) focused on the development of medical cannabis products, announces today receiving an IMC-GAP approval from the Israel ... Read More